Thomas Kipps

Author PubWeight™ 51.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002 32.26
2 Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006 5.72
3 Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005 3.35
4 Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia. Blood 2008 2.18
5 Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 2010 1.94
6 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010 1.79
7 Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci U S A 2008 1.62
8 Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity. Leuk Res 2005 1.44
9 IRF4 mutations in chronic lymphocytic leukemia. Blood 2011 1.05
10 Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer Genet Cytogenet 2010 0.97
11 A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia. Leuk Lymphoma 2014 0.76
12 Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events. Clin Adv Hematol Oncol 2010 0.75